Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
Subscribe To Our Newsletter & Stay Updated